Laura A. Kuusalo

Turku, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

The impact of smoking and obesity on secukinumab effectiveness in psoriatic arthritis: real-world evidence from 1202 European patients.

The impact of smoking and obesity on secukinumab effectiveness in psoriatic arthritis: real-world evidence from 1202 European patients.

Journal: EULAR rheumatology open

Published: June 29, 2026

Work disability in rheumatoid arthritis-is the gap finally closing?

Work disability in rheumatoid arthritis-is the gap finally closing?

Journal: Rheumatology (Oxford, England)

Published: April 28, 2026

Physician global assessment in rheumatoid arthritis-is there any logic?

Physician global assessment in rheumatoid arthritis-is there any logic?

Journal: Rheumatology advances in practice

Published: November 18, 2025

Impact of cardiometabolic comorbidities on clinical characteristics, prescription patterns and retention rate of first b/tsDMARD treatment in 5299 European real-world patients with psoriatic arthritis.

Impact of cardiometabolic comorbidities on clinical characteristics, prescription patterns and retention rate of first b/tsDMARD treatment in 5299 European real-world patients with psoriatic arthritis.

Journal: RMD open

Published: October 28, 2025

Assessing internal construct validity of DAPSA and DAPSA28 in psoriatic arthritis: a European observational study using confirmatory factor analysis and additional psychometric testing.

Assessing internal construct validity of DAPSA and DAPSA28 in psoriatic arthritis: a European observational study using confirmatory factor analysis and additional psychometric testing.

Journal: RMD open

Published: July 07, 2025

Defining Bath Ankylosing Spondylitis Disease Activity Index Cut-off Values for Disease Activity States in a Multinational European Cohort of Patients With Axial Spondyloarthritis.

Defining Bath Ankylosing Spondylitis Disease Activity Index Cut-off Values for Disease Activity States in a Multinational European Cohort of Patients With Axial Spondyloarthritis.

Journal: ACR open rheumatology

Published: April 17, 2025

Does different administration method of methotrexate matter in early rheumatoid arthritis? An exploratory register-based study.

Does different administration method of methotrexate matter in early rheumatoid arthritis? An exploratory register-based study.

Journal: Clinical and experimental rheumatology

Published: March 31, 2025

Predictors of Secukinumab Treatment Response and Continuation in Axial Spondyloarthritis: Results From the EuroSpA Research Collaboration Network.

Predictors of Secukinumab Treatment Response and Continuation in Axial Spondyloarthritis: Results From the EuroSpA Research Collaboration Network.

Journal: The Journal of rheumatology

Published: January 02, 2025

Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries.

Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries.

Journal: Arthritis care & research

Published: February 21, 2024

Intense symptoms of pain are associated with poor sleep, fibromyalgia, depression and sleep apnea in patients with rheumatoid arthritis and psoriatic arthritis. A register-based study.

Intense symptoms of pain are associated with poor sleep, fibromyalgia, depression and sleep apnea in patients with rheumatoid arthritis and psoriatic arthritis. A register-based study.

Journal: Joint bone spine

Published: December 03, 2023

Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice.

Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice.

Journal: Seminars in arthritis and rheumatism

Published: September 28, 2023

Deep learning enables automatic detection of joint damage progression in rheumatoid arthritis-model development and external validation.

Deep learning enables automatic detection of joint damage progression in rheumatoid arthritis-model development and external validation.

Journal: Rheumatology (Oxford, England)

Published: September 10, 2023

Showing 1-12 of 24

Last Updated: 09/26/2026